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I. Purpose 
 
Metastasis is a process in which tumor initiating cells (TICs) disseminate from 
the primary tumor to settle in distant organs as dormant seeds that become reactivated 
after months or years to proliferate and form therein clinically overt cancer deposits, 
an upshot that results in clinical complications accounting for 90% of deaths in 
patients with solid tumors. The metastatic cascade is reflective of extensive epigenetic 
and genetic tweaks of heterogenous cell populations in the primary tumor that 
eventually favor the selection of rare subclones equipped with a competent set of 
molecular alterations capable of supporting their survival, adaptation then 
proliferation in the hostile and deadly microenvironment of distant organs. Therefore, 
identification of clinically relevant metastasis genes and the function of their protein 
product can provide insights to tackle key steps in the metastatic cascade at the 
molecular level.  
PMEPA1/TMEPAI, a type Ib transmembrane protein whose transcription is 
upregulated by androgens, TGF-β signaling, Wnt signaling and EGF signaling, is 
implicated in regulation of important signaling pathways that are modified in 
oncogenic transformation including suppression of TGF-β/Smad and androgen 
signaling, as well as activation of PI3K/AKT signaling through negative regulation of 
PTEN. For its role in metastasis, reports are conflicting likely reflective of the 
molecular context in which PMEPA1 works. Hence, the purpose of this study was to 
experimentally investigate the role of PMEPA1 in metastasis of the human breast 
cancer cell line MDA-MB-231 to the lung with a focus on two important signaling 
pathways regulated by PMEPA1: TGF-β/Smad and PI3K/AKT signaling. 
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II. Materials and Methods 
 
A CRISPR-Cas9 system was used to establish PMEPA1 knockout (KO) MDA-
MB-231 cell clones. Two different single guide RNAs (sgRNA #1 and sgRNA #3) 
designed using the CRISPR Design Online Tool (https://crispr.dbcls.jp) were 
employed to induce a double-stranded DNA break (DSB) in Exon 2 of the human 
PMEPA1 gene. Two cell clones (PMEPA1 KO 1-3 and PMEPA1 KO 3-5) were 
selected and expanded after screening for TGF-β-induced PMEPA1 protein 
expression levels that confirmed loss of PMEPA1 protein expression in PMEPA1 KO 
MDAMB231 cell lines. Luciferase (Luc)- or Green Fluorescence Protein (GFP)-
expressing PMEPA1 KO or parental MDAMB231 cells were established using a 
lentivirus Luc- or GFP-expressing vector (CSII-CMV-MCS-IRES2-Bsd-Luc/GFP), 
respectively. PMEPA1 KO and parental MDA-MB-231 cell lines were used for 
investigation of PMEPA1 role in cell proliferation in vivo by subcutaneous injection 
of tumor cells into the left flank of female NOD/ShiJic-scid mice and in vitro both at 
high seeding density by cell proliferation assay and at low density by colony 
formation assay. Two experimental lung metastasis assays were performed either after 
subcutaneous or after tail vein injection of the tumor cells in age-matched female 
NOD/ShiJic-scid mice. When needed, the luciferase-labelled tumor cells were tracked 
in vivo by non-invasive bioluminescence imaging using In Vitro Imaging System 
(IVIS). Lung metastatic burden was assessed by microscopic examination of H&E-
stained whole-lung sections at 3 different coronal levels for metastatic lung lesions. 
Total RNA, extracted from surgically resected tumor xenografts or from in vitro cell 
culture, was used to identify gene expression alterations after KO of PMEPA1 
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through quantitative real-time PCR (qRT-PCR) or RNA sequencing (RNA-seq). Gene 
set enrichment analysis (GSEA) was used to identify clinical association between 
altered expression of PMEPA1 and changes in PMEPA1-related signaling pathways 
in The Cancer Genome Atlas (TCGA) invasive breast cancer cases (BRCA). 
According to the experimental variable, statistical analysis was performed using 
Student T-test in Excel, One-way/ Welch’s ANOVA and the appropriate Post Hoc test 
in SPSS (IBM, version 24) or Fisher's exact test in GraphPad Prism 7. 
 
III. Results 
 
The functional impact of PMEPA1 KO was validated by PMEPA1 KO-mediated 
promotion of TGF-β/Smad signaling as expected. The data initially showed 
suppression of in vivo tumor growth and lung metastasis after subcutaneous injection 
of the tumor cells in age-matched female NOD/ShiJic-scid mice but not of in vitro 
monolayer cell proliferation at high seeding density in CRISPR-Cas9-mediated 
PMEPA1 KO MDA-MB-231 cell lines compared with parental MDA-MB-231 cells, 
a phenomenon that could not be attributed to molecular changes related to cell 
proliferation and/or survival such as MYC transcription that showed marginal in vivo 
downregulation and in vitro upregulation of MYC expression compared with those of 
the parental MDA-MB-231 cells. Rather, this difference reflects, at least partially, the 
PMEPA1 KO-mediated suppression of the proangiogenic factors VEGFA and IL8 
which are salient for in vivo but not in vitro growing cells and are also substantial for 
initiation of lung metastasis through promotion of angiogenesis.  
The data showed, however, suppression of in vitro monolayer cell proliferation at 
low seeding density in CRISPR-Cas9-mediated PMEPA1 KO MDA-MB-231 cell 
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lines compared with parental MDA-MB-231 cells suggesting that PMEPA1 has a role 
in initiating and/or maintaining proliferation from single cells under low seeding 
density condition that is masked under high seeding density condition and that the 
discrepancy between in vivo tumor growth and in vitro cell proliferation in monolayer 
adherent cell culture condition of PMEPA1 KO cell lines at high seeding density 
probably reflects differences in other mediators in addition to those related to 
angiogenesis. 
My experiments revealed that both parental and PMEPA1 KO MDA-MB-231 
cells could comparably provide growth signals enough to further drive cell 
proliferation. At high seeding density, GFP-expressing PMEPA1 KO MDA-MB-231 
cells had a stronger response than this of GFP-expressing parental cells to the growth 
signals provided at high seeding density by the surrounding Non-GFP-expressing 
population of either PMEPA1 KO or parental cell, respectively. Yet, GFP-expressing 
PMEPA1 KO MDA-MB-231 cells kept showing less capacity than parental cells to 
proliferate from single cells even on switching the surrounding Non-GFP-expressing 
population either to parental or to PMEPA1 KO MDA-MB-231 cells, respectively, 
supporting the observation that KO of PMEPA1 does not affect the growth signals 
provided by non-GFP-expressing cells at high seeding density. Collectively, the data 
suggest that the slow cell proliferation associated with KO of PMEPA1 in MDA-MB-
231 cells at low seeding density is related to changes in intrinsic molecular properties.   
Further analysis revealed a salient role of enhancing PI3K/AKT signaling, in contrast 
to the marginal role of suppressing TGF-β/Smad signaling, in driving single cell 
proliferation either of parental or of PMEPA1 KO MDA-MB-231 cells at low seeding 
density. In TCGA invasive breast cancer cases (BRCA), upregulation of PMEPA1 
was clinically associated with suppression of PTEN activity. My data showed also 
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that PMEPA1 KO MDA-MB-231 cells have tendency to form smaller metastatic lung 
lesions than parental MDA-MB-231 cells after tail vein injection of tumor cells.  
 
IV. Discussion 
 
Impaired growth of PMEPA1 KO cell line-derived tumor xenografts is 
consistent with several reports that dominantly indicate a tumorigenic function of 
PMEPA1. PMEPA1 KO-mediated induction of TGF-β signaling alone could not 
sufficiently explain this in vivo phenotype since MDA-MB-231 cell growth is poorly 
inhibited by TGF-β. Rather, the discrepancy between in vivo tumor growth and 
metastasis on the one hand and in vitro cell proliferation in monolayer adherent cell 
culture condition of PMEPA1 KO cell lines at high seeding density on the other hand 
partially reflects the marked impact of PMEPA1 KO-mediated suppression of critical 
proangiogenic mediators, including IL8 and VEGFA, and therefore impaired 
angiogenesis on in vivo tumor growth and on metastasis which is negligible on in 
vitro proliferating cells that evenly receive nutrients from enriched medium. 
The in vitro proliferation from single cells mimics a critical step in the early 
metastatic colonization of distant organs: Naturally, aggressive tumors shed thousands 
of cancer cells in the circulation every day. However, most of them perish and only 
few are competent enough to survive then to proliferate again after a latency period. 
Hence, the role of PMEPA1 in initiating and/or maintaining proliferation from single 
cells at low density suggests that PMEPA1 supports metastasis not only through 
maintaining transcription of important proangiogenic mediators and promotion of 
angiogenesis, but also probably through initiation of proliferation from single cells 
early during distant organ colonization. Indeed, PMEPA1 KO MDA-MB-231 cells 
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tended to form smaller metastatic lung lesions than those of parental MDA-MB-231 
cells after tail vein injection of tumor cells. Yet, the mechanism is still elusive.  
The data showed that both parental and PMEPA1 KO MDA-MB-231 cells 
could comparably provide growth signals enough to further drive cell proliferation at 
high seeding density suggesting insignificant impact of PMEPA1 knockout on 
supportive growth signals provided by MDA-MB-231 cells at high seeding sensity, a 
conclusion that was further supported on tracking proliferation of parental and of 
PMEPA1 KO cell colonies after switching the surrounding cells to PMEPA1 KO or to 
parental cells, respectively, that resulted in insignificant difference. As a result, my 
focus was directed to the role of PMEPA1 in modulating intrinsic molecular 
properties. 
 The data attest a critical role of PI3K/AKT signaling in the proliferation of both 
parental and PMEPA1 KO MDA-MB-231 cells at low seeding density. Therefore, 
PMEPA1 KO-mediated attenuation of PI3K/AKT signaling probably contributes to 
the reduction of proliferation from single cells at low seeding density in PMEPA1 KO 
MDA-MB-231 cells. At the clinical level, upregulation of PMEPA1 was associated 
with suppression of PTEN activity.  Nevertheless, these data are still short on a direct 
evidence to support this putative mechanism. For early metastatic colonization, 
amplification of AKT signaling is a protective response that safeguards metastatic 
cancer cell survival in distant organs.  
Although the experiments, so far, did not figure out how PMEPA1 KO MDA-
MB-231 compensate at high seeding density for their impaired proliferation at low 
seeding density, the current findings showed that PMEPA1 KO MDA-MB-231 cells 
have a stronger response than parental cells to the provided growth signals at high 
seeding density, a trait that enables them to greatly neutralize molecular differences 
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that suppress their proliferation at low seeding density and to almost catch up with the 
proliferation rate of parental cells. 
 
V. Conclusion 
 
To summarize, the data show suppression of in vivo tumor growth and lung 
metastasis and of in vitro monolayer cell proliferation at low, but not at high, seeding 
density in CRISPR-Cas9-mediated PMEPA1 KO MDA-MB-231 cell lines compared 
with parental MDA-MB-231 cells.  This discrepancy reflects, at least partially, the 
PMEPA1 KO-mediated suppression of the proangiogenic factors VEGFA and IL8 
which are salient for in vivo but not in vitro growing cells and are also substantial for 
initiation of lung metastasis. In addition, PMEPA1 KO MDA-MB-231 cells tended to 
have smaller metastatic lung lesions than those of parental MDA-MB-231 cells in 
lung metastatic colonization assay after tail vein injection of tumor cells. My data also 
put a high gloss on the role of PI3K/AKT signaling in proliferation of both parental 
and PMEPA1 KO cells at low seeding density. The data also reveal that PMEPA1 KO 
MDA-MB-231 cells have a stronger response than parental cell to the provided 
growth signals at high seeding density that enable them to catch up with the 
proliferation rate of parental cells although the molecular mechanism is yet to be 
identified.  
 
